Big Pharma’s Covid-19 Profiteers How the race to develop treatments and a vaccine will create a historic windfall for the industry — and e...
Big Pharma’s Covid-19 Profiteers How the race to develop treatments and a vaccine will create a historic windfall for the industry — and e...
Buttonwood The SPAC hack The latest twist in the power struggle between Silicon Valley and Wall Street In an episode of “The Phil S...
Gold’s evolution into a ‘must-have’ asset is storing up trouble Price rise is being driven by investors adding the metal to long-term port...
DETAILED 2020/2021 PRICE FORECASTS FOR GOLD & SILVER Chris Vermeullen This research article may get a bit technical, so please e...
The Future of American Liberalism What Biden can learn from F.D.R. By David Brooks Franklin Roosevelt’s New Deal brought balance to a...
How to Prevent the Looming Sovereign-Debt Crisis From Latin America’s lost decade in the 1980s to the more recent Greek crisis, there are ...
A sigh of relief, a gasp of breath In emerging markets, short-term panic gives way to long-term worry Emergency measures have helped kee...
The parallel universe of private equity returns If IRR metrics had any sound basis in fact, we would all be as rich as Croesus Jonathan ...
The Mysterious Life of Birds Who Never Come Down Swifts spend all their time in the sky. What can their journeys tell us about the future?...
Responsibility or Ruin Although the top priority today is to contain the COVID-19 pandemic and mitigate its economic fallout, we must not...